4//SEC Filing
Burkavage Brian 4
Accession 0000905148-23-001527
CIK 0001865494other
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 5:37 PM ET
Size
6.0 KB
Accession
0000905148-23-001527
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Burkavage Brian
Chief Accounting Officer
Transactions
- Purchase
Common Stock
2023-11-22$1.03/sh+5,000$5,175→ 11,500 total - Purchase
Common Stock
2023-11-21$0.99/sh+5,000$4,950→ 6,500 total
Footnotes (1)
- [F1]The transaction was executed in multiple trades in prices ranging from $1.03 to $1.04, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.
Documents
Issuer
IO Biotech, Inc.
CIK 0001865494
Entity typeother
Related Parties
1- filerCIK 0001865633
Filing Metadata
- Form type
- 4
- Filed
- Nov 23, 7:00 PM ET
- Accepted
- Nov 24, 5:37 PM ET
- Size
- 6.0 KB